Beta-blocker therapy in the cardiac arrhythmia suppression trial
- 1 October 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 74 (7), 674-680
- https://doi.org/10.1016/0002-9149(94)90308-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Risk of Determining Risk with Multivariable ModelsAnnals of Internal Medicine, 1993
- β-Blockers after Myocardial Infarction: Influence of First-Year Clinical Course on Long-Term EffectivenessAnnals of Internal Medicine, 1993
- Cumulative Meta-Analysis of Therapeutic Trials for Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial InfarctionNew England Journal of Medicine, 1992
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failureJournal of the American College of Cardiology, 1990
- Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.Circulation, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.Circulation, 1986
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985